These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38730601)

  • 1. Clinical Management of Intraductal Carcinoma of the Prostate.
    Wasinger G; Cussenot O; Compérat E
    Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features and Prognostic Significance of Intraductal Carcinoma of the Prostate.
    Montironi R; Zhou M; Magi-Galluzzi C; Epstein JI
    Eur Urol Oncol; 2018 May; 1(1):21-28. PubMed ID: 31100224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.
    Risbridger GP; Taylor RA; Clouston D; Sliwinski A; Thorne H; Hunter S; Li J; Mitchell G; Murphy D; Frydenberg M; Pook D; Pedersen J; Toivanen R; Wang H; Papargiris M; Lawrence MG; Bolton DM
    Eur Urol; 2015 Mar; 67(3):496-503. PubMed ID: 25154392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical intraductal proliferation and intraductal carcinoma of the prostate on core needle biopsy: a comparative clinicopathological and molecular study with a proposal to expand the morphological spectrum of intraductal carcinoma.
    Shah RB; Yoon J; Liu G; Tian W
    Histopathology; 2017 Nov; 71(5):693-702. PubMed ID: 28570007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists.
    Gandhi JS; Smith SC; Paner GP; McKenney JK; Sekhri R; Osunkoya AO; Baras AS; DeMarzo AM; Cheville JC; Jimenez RE; Trpkov K; Colecchia M; Ro JY; Montironi R; Menon S; Hes O; Williamson SR; Hirsch MS; Netto GJ; Fine SW; Sirohi D; Kaushal S; Sangoi A; Robinson BD; Kweldam CF; Humphrey PA; Hansel DE; Schultz L; Magi-Galluzzi C; Przybycin CG; Shah RB; Mehra R; Kunju LP; Aron M; Kryvenko ON; Kench JG; Kuroda N; Tavora F; van der Kwast T; Grignon DJ; Epstein JI; Reuter VE; Amin MB
    Am J Surg Pathol; 2020 May; 44(5):673-680. PubMed ID: 31876580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.
    Han B; Suleman K; Wang L; Siddiqui J; Sercia L; Magi-Galluzzi C; Palanisamy N; Chinnaiyan AM; Zhou M; Shah RB
    Am J Surg Pathol; 2010 Apr; 34(4):478-85. PubMed ID: 20220513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraductal carcinoma of the prostate: precursor or aggressive phenotype of prostate cancer?
    Bonkhoff H; Wheeler TM; van der Kwast TH; Magi-Galluzzi C; Montironi R; Cohen RJ
    Prostate; 2013 Mar; 73(4):442-8. PubMed ID: 22949099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal carcinoma of the prostate in an Irish prostate cancer patient cohort-an aggressive pathology and a strong familial link.
    Haroon UM; O'Grady-Coyne S; Davis NF; Gullmann C; Forde JC; Smyth GP; Power RE; Cheema IA; McLornan L
    Prostate Int; 2020 Sep; 8(3):107-111. PubMed ID: 33102390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Features and Clinical Implications of Intraductal Carcinoma of the Prostate.
    Kang M; Lee H; Byeon SJ; Kwon GY; Jeon SS
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal carcinoma of the prostate in prostate biopsy samples: correlation with aggressive pathological features after radical prostatectomy and prognostic value in high-risk prostate cancer.
    Zhu S; Zhao JG; Chen JR; Liu ZH; Sun GX; Wang ZP; Ni YC; Dai JD; Shen PF; Zeng H
    Asian J Androl; 2020; 22(5):519-525. PubMed ID: 31710002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives.
    Zong Y; Montironi R; Massari F; Jiang Z; Lopez-Beltran A; Wheeler TM; Scarpelli M; Santoni M; Cimadamore A; Cheng L
    Eur Urol Focus; 2021 Sep; 7(5):955-963. PubMed ID: 33132109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical intraductal proliferation detected in prostate needle biopsy is a marker of unsampled intraductal carcinoma and other adverse pathological features: a prospective clinicopathological study of 62 cases with emphasis on pathological outcomes.
    Shah RB; Nguyen JK; Przybycin CG; Reynolds JP; Cox R; Myles J; Klein E; McKenney JK
    Histopathology; 2019 Sep; 75(3):346-353. PubMed ID: 31012493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-Depth Comparison of Genetic Variants Demonstrates a Close Relationship Between Invasive and Intraductal Components of Prostate Cancer.
    Vormittag-Nocito E; Acosta AM; Agarwal S; Narayan KD; Kumar R; Al Rasheed MRH; Kajdacsy-Balla A; Behm FG; Mohapatra G
    Mod Pathol; 2023 Jun; 36(6):100130. PubMed ID: 36933394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review Links the Prevalence of Intraductal Carcinoma of the Prostate to Prostate Cancer Risk Categories.
    Porter LH; Lawrence MG; Ilic D; Clouston D; Bolton DM; Frydenberg M; Murphy DG; Pezaro C; Risbridger GP; Taylor RA
    Eur Urol; 2017 Oct; 72(4):492-495. PubMed ID: 28342640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of IDC-P as predictive factor after intensity-modulated radiation therapy.
    Aizawa R; Tsuzuki T; Haga H; Nakamura K; Ogata T; Inoue T; Kobayashi T; Akamatsu S; Goto T; Ogawa O; Mizowaki T
    Cancer Sci; 2022 Jul; 113(7):2425-2433. PubMed ID: 35514196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraductal Adenocarcinoma of the Prostate With Cribriform or Papillary Ductal Morphology: Rare Biopsy Cases Lacking Associated Invasive High-grade Carcinoma.
    Russell DH; Epstein JI
    Am J Surg Pathol; 2022 Feb; 46(2):233-240. PubMed ID: 34619708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P).
    Zhu S; Zhao J; Nie L; Yin W; Zhang Y; Zhao F; Ni Y; Zhang X; Wang Z; Dai J; Liu Z; Chen J; Zeng Y; Wang Z; Sun G; Liang J; Zhao X; Zhu X; Tao R; Yang J; He B; Chen N; Shen P; Zeng H
    BMC Med; 2022 Jul; 20(1):237. PubMed ID: 35864546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal carcinoma of the prostate: What we know and what we do not know.
    Chen X; Ding B; Zhang P; Geng S; Xu J; Han B
    Pathol Res Pract; 2018 May; 214(5):612-618. PubMed ID: 29628124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study.
    Diop MK; Molina OE; Birlea M; LaRue H; Hovington H; Têtu B; Lacombe L; Bergeron A; Fradet Y; Trudel D
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.
    Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
    Int J Clin Exp Pathol; 2014; 7(5):2518-26. PubMed ID: 24966964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.